Reuters logo
BRIEF-Swedish Orphan Biovitrum says Alprolix approved for use in Saudi Arabia‍​
October 25, 2017 / 6:23 AM / a month ago

BRIEF-Swedish Orphan Biovitrum says Alprolix approved for use in Saudi Arabia‍​

Oct 25 (Reuters) - Swedish Orphan Biovitrum Ab (Publ) says:

* Alprolix approved for treatment of Hemofili B in Saudi Arabia.‍​ Source text for Eikon: Further company coverage: (Reporting By Johan Sennero)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below